Grant: Project Grant

Antibodies are naturally produced by the body's immune cells as defense against infection. These molecules, produced by an external source, could also be used as medicine to treat a wide range of diseases, including cancer, multiple sclerosis, and rheumatoid arthritis. A key barrier in developing antibody-based medicines is producing sufficient quantities of these molecules for various stages of rigorous testing. Antibodies are typically manufactured using producer cells that are grown in the laboratory. This project will develop a technology to develop better producer cells in order to increase their productivity. This capability will dramatically reduce the timelines required to develop antibody-based medicines, resulting in faster and more cost-effective medicines for patients.